| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.56e-09 | 37 | 134 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 5.55e-09 | 38 | 134 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 6.17e-07 | 11 | 134 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | 9.05e-07 | 27 | 134 | 5 | GO:0030548 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | 1.10e-06 | 28 | 134 | 5 | GO:0099602 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.84e-06 | 14 | 134 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.06e-05 | 21 | 134 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.39e-05 | 46 | 134 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 2.41e-05 | 9 | 134 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 2.41e-05 | 9 | 134 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.02e-04 | 14 | 134 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.08e-04 | 37 | 134 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.20e-04 | 38 | 134 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 1.34e-04 | 3 | 134 | 2 | GO:0008184 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.96e-04 | 262 | 134 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 DIS3L2 POLR2B ERVK-7 ERVK-10 ERVK-8 DDX20 DNA2 TOP3B DDX4 MOV10 DNMT3L CDK7 | 4.07e-04 | 645 | 134 | 13 | GO:0140640 |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 4.41e-04 | 5 | 134 | 2 | GO:0004645 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 5.63e-04 | 211 | 134 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 5.68e-04 | 152 | 134 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | protein kinase binding | IL12RB2 IL31RA COPB2 CEP192 SPDYE18 TRIM64C SPDYE2 FAM83G ZFYVE26 SPDYE5 PLD2 SPDYE2B SPDYE6 MAP3K2 SPDYE16 | 7.76e-04 | 873 | 134 | 15 | GO:0019901 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERVK-6 PDE6A DIS3L2 ABHD12B ERVK-7 ERVK-10 LCAT INPP5F PTPRU ERVK-8 GPCPD1 PLD2 DNA2 PLCE1 | 1.07e-03 | 807 | 134 | 14 | GO:0016788 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB3 ERVK-6 KALRN POLR2B CDK19 INSRR OAS3 ERVK-7 CHEK1 ERVK-10 MAP3K3 DGKK ERVK-8 MAP3K2 CDK7 | 1.59e-03 | 938 | 134 | 15 | GO:0016772 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.97e-03 | 79 | 134 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 2.04e-03 | 417 | 134 | 9 | GO:0140098 | |
| GeneOntologyMolecularFunction | kinase binding | IL12RB2 IL31RA COPB2 CEP192 SPDYE18 TRIM64C SPDYE2 FAM83G ZFYVE26 SPDYE5 PLD2 SPDYE2B SPDYE6 MAP3K2 SPDYE16 | 2.18e-03 | 969 | 134 | 15 | GO:0019900 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.25e-03 | 136 | 134 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.25e-03 | 136 | 134 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 USP29 ERVK-7 ERVK-9 ERVK-10 MEP1B ERVK-8 ERVK-19 ERVK-24 | 2.50e-03 | 430 | 134 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 DPYD MYCBP2 KDM5A KDM4C ERVK-7 ERVK-9 ERVK-10 TRIM64C HEPH MEP1B AHCY ERVK-8 ERVK-19 TADA2A DMD ERVK-24 | 2.55e-03 | 1189 | 134 | 17 | GO:0046914 |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 MYCBP2 KDM5A KDM4C ERVK-7 ERVK-9 ERVK-10 TRIM64C MEP1B ERVK-8 ERVK-19 TADA2A DMD ERVK-24 | 2.67e-03 | 891 | 134 | 14 | GO:0008270 |
| GeneOntologyMolecularFunction | vinculin binding | 3.32e-03 | 13 | 134 | 2 | GO:0017166 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 3.34e-03 | 288 | 134 | 7 | GO:0016757 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 4.42e-07 | 25 | 130 | 5 | GO:0045737 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | 8.05e-07 | 28 | 130 | 5 | GO:1904031 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.03e-06 | 13 | 130 | 4 | GO:0015074 | |
| Domain | Spy1 | 5.54e-09 | 11 | 125 | 5 | PF11357 | |
| Domain | Speedy | 5.54e-09 | 11 | 125 | 5 | IPR020984 | |
| Domain | Ca_chan_IQ | 1.00e-05 | 7 | 125 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 1.00e-05 | 7 | 125 | 3 | PF08763 | |
| Domain | VDCC_a1su_IQ | 1.00e-05 | 7 | 125 | 3 | IPR014873 | |
| Domain | GPHH | 1.00e-05 | 7 | 125 | 3 | PF16905 | |
| Domain | GPHH_dom | 1.00e-05 | 7 | 125 | 3 | IPR031649 | |
| Domain | VDCCAlpha1 | 3.39e-05 | 10 | 125 | 3 | IPR002077 | |
| Domain | FN3 | 3.49e-05 | 185 | 125 | 8 | SM00060 | |
| Domain | Filamin | 4.64e-05 | 11 | 125 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 4.64e-05 | 11 | 125 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 4.64e-05 | 11 | 125 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 4.64e-05 | 11 | 125 | 3 | IPR017868 | |
| Domain | FN3_dom | 8.25e-05 | 209 | 125 | 8 | IPR003961 | |
| Domain | ARM-type_fold | 9.52e-05 | 339 | 125 | 10 | IPR016024 | |
| Domain | fn3 | 1.10e-04 | 162 | 125 | 7 | PF00041 | |
| Domain | PHOSPHORYLASE | 1.33e-04 | 3 | 125 | 2 | PS00102 | |
| Domain | Glycg_phsphrylas | 1.33e-04 | 3 | 125 | 2 | IPR011833 | |
| Domain | Glyco_trans_35 | 1.33e-04 | 3 | 125 | 2 | IPR000811 | |
| Domain | Phosphorylase | 1.33e-04 | 3 | 125 | 2 | PF00343 | |
| Domain | - | EPHB3 ILDR2 IL12RB2 FLNB FLNC IL31RA COL12A1 KALRN MYCBP2 INSRR PTPRU FAM187B GPCPD1 IGSF23 | 1.42e-04 | 663 | 125 | 14 | 2.60.40.10 |
| Domain | Ig-like_fold | EPHB3 ILDR2 IL12RB2 FLNB FLNC IL31RA COL12A1 KALRN MYCBP2 INSRR PTPRU FAM187B GPCPD1 IGSF23 | 2.72e-04 | 706 | 125 | 14 | IPR013783 |
| Domain | FN3 | 3.88e-04 | 199 | 125 | 7 | PS50853 | |
| Domain | Galactose-bd-like | 4.23e-04 | 94 | 125 | 5 | IPR008979 | |
| Domain | ACTININ_2 | 4.70e-04 | 23 | 125 | 3 | PS00020 | |
| Domain | ACTININ_1 | 4.70e-04 | 23 | 125 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.70e-04 | 23 | 125 | 3 | IPR001589 | |
| Domain | SEC14 | 6.04e-04 | 25 | 125 | 3 | SM00516 | |
| Domain | - | 7.43e-04 | 222 | 125 | 7 | 1.25.10.10 | |
| Domain | CRAL_TRIO | 7.61e-04 | 27 | 125 | 3 | PS50191 | |
| Domain | CRAL-TRIO_dom | 8.48e-04 | 28 | 125 | 3 | IPR001251 | |
| Domain | CH | 1.46e-03 | 73 | 125 | 4 | PS50021 | |
| Domain | CH-domain | 1.61e-03 | 75 | 125 | 4 | IPR001715 | |
| Domain | MIF4G | 1.93e-03 | 10 | 125 | 2 | SM00543 | |
| Domain | JmjN | 1.93e-03 | 10 | 125 | 2 | SM00545 | |
| Domain | IG_FLMN | 1.93e-03 | 10 | 125 | 2 | SM00557 | |
| Domain | MIF4G | 1.93e-03 | 10 | 125 | 2 | PF02854 | |
| Domain | JmjN | 1.93e-03 | 10 | 125 | 2 | PF02375 | |
| Domain | MIF4G-like_typ-3 | 1.93e-03 | 10 | 125 | 2 | IPR003890 | |
| Domain | JMJN | 1.93e-03 | 10 | 125 | 2 | PS51183 | |
| Domain | JmjN | 1.93e-03 | 10 | 125 | 2 | IPR003349 | |
| Domain | ARM-like | 2.29e-03 | 270 | 125 | 7 | IPR011989 | |
| Domain | IL6Ra-bind | 2.35e-03 | 11 | 125 | 2 | PF09240 | |
| Domain | TypeI_recpt_CBD | 2.35e-03 | 11 | 125 | 2 | IPR015321 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 4.14e-05 | 11 | 91 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 4.14e-05 | 11 | 91 | 3 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 4.14e-05 | 11 | 91 | 3 | M47958 | |
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | 9.80e-11 | 9 | 134 | 5 | 36272447 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 2.11e-10 | 4 | 134 | 4 | 10469592 | |
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | 9.89e-10 | 13 | 134 | 5 | 15611625 | |
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | 4.70e-09 | 17 | 134 | 5 | 15574121 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 38996073 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 5.59e-08 | 3 | 134 | 3 | 24523520 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 8.34e-08 | 94 | 134 | 7 | 21542922 | |
| Pubmed | 1.02e-07 | 12 | 134 | 4 | 14557543 | ||
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 2.23e-07 | 4 | 134 | 3 | 37141091 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 2.23e-07 | 4 | 134 | 3 | 32616470 | |
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 7983737 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B FLNB FLNC DIS3L2 MYCBP2 POLR2B COPB2 OAS3 SLC3A2 CSE1L NF1 PELO PSME4 UPF2 WDR11 EIF4G1 AHCY PYGB DDX20 MOV10 | 2.59e-07 | 1353 | 134 | 20 | 29467282 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | SAMD1 MYCBP2 UGGT1 POLR2B COPB2 SPCS2 SLC3A2 CSE1L PELO PSME4 WDR11 EIF4G1 AHCY PYGB DDX20 ALDH3A2 DNA2 GPAT4 WDR48 | 3.81e-07 | 1257 | 134 | 19 | 37317656 |
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 8825650 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 5.56e-07 | 5 | 134 | 3 | 12629516 | |
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 11296258 | ||
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 15451373 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 1.11e-06 | 6 | 134 | 3 | 35324301 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 1.11e-06 | 6 | 134 | 3 | 12827191 | |
| Pubmed | 1.11e-06 | 6 | 134 | 3 | 15063128 | ||
| Pubmed | 1.11e-06 | 6 | 134 | 3 | 9238069 | ||
| Pubmed | PDS5B FLNB FLNC MYCBP2 UGGT1 COPB2 USP24 CSE1L NF1 EIF4G1 PYGB DDX20 MOV10 | 1.59e-06 | 653 | 134 | 13 | 22586326 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 1.94e-06 | 7 | 134 | 3 | 35176221 | |
| Pubmed | DRC7 FLNB FLNC SPCS2 SLC3A2 CHMP7 WDR11 EIF4G1 VPS13A AHCY ALDH3A2 GPAT4 | 2.22e-06 | 568 | 134 | 12 | 37774976 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDS5B DENND4A MYCBP2 UGGT1 POLR2B CDK19 COPB2 SLC3A2 PELO UBAC1 EIF4G1 AHCY FAM83G PYGM DDX20 TNPO3 MOV10 MAP3K2 | 2.31e-06 | 1284 | 134 | 18 | 17353931 |
| Pubmed | 3.25e-06 | 104 | 134 | 6 | 9205841 | ||
| Pubmed | FLNB FLNC DENND4A COL12A1 KALRN MYCBP2 KDM5A ALMS1 UPF2 PYGM PLCE1 | 3.85e-06 | 497 | 134 | 11 | 23414517 | |
| Pubmed | 4.62e-06 | 9 | 134 | 3 | 16382099 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A MYCBP2 KDM5A ARHGAP17 CEP192 CHEK1 INPP5F MAP3K3 NF1 ALMS1 EIF4G1 FAM83G TNPO3 MAP3K2 | 6.43e-06 | 861 | 134 | 14 | 36931259 |
| Pubmed | PDS5B CACNA1E FLNB FLNC DENND4A PDE6A KDM5A SPEF2 UGGT1 FER1L6 SLC3A2 DGKK EIF4G1 VPS13A DMD POFUT2 TOP3B RBBP9 | 1.13e-05 | 1442 | 134 | 18 | 35575683 | |
| Pubmed | MYCBP2 UGGT1 POLR2B COPB2 TRIOBP CEP192 PTPRU SLC3A2 CSE1L WDR11 VPS13A DMD ALDH3A2 TOP3B WDR48 | 1.36e-05 | 1049 | 134 | 15 | 27880917 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 21333552 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15610184 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 1.47e-05 | 2 | 134 | 2 | 23426690 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 8621389 | ||
| Pubmed | NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | 1.47e-05 | 2 | 134 | 2 | 34040258 | |
| Pubmed | A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha. | 1.47e-05 | 2 | 134 | 2 | 9694715 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 23376566 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 38155373 | ||
| Pubmed | MEKK2 mediates aberrant ERK activation in neurofibromatosis type I. | 1.47e-05 | 2 | 134 | 2 | 33177525 | |
| Pubmed | The Kelch-like protein 1 modulates P/Q-type calcium current density. | 1.47e-05 | 2 | 134 | 2 | 17289272 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 16381801 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 24755485 | ||
| Pubmed | The limits of promiscuity: isoform-specific dimerization of filamins. | 1.47e-05 | 2 | 134 | 2 | 12525170 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.47e-05 | 2 | 134 | 2 | 9460924 | |
| Pubmed | Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. | 1.47e-05 | 2 | 134 | 2 | 12074836 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 25130497 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15050706 | ||
| Pubmed | RIPOR2 MYCBP2 USP24 ERVK-10 INPP5F PTPRU HEPH MAP3K3 SLC3A2 FAT1 NF1 RALGPS1 VPS13A FAM83G POFUT2 TOP3B | 1.90e-05 | 1215 | 134 | 16 | 15146197 | |
| Pubmed | 2.46e-05 | 15 | 134 | 3 | 20188150 | ||
| Pubmed | 2.46e-05 | 15 | 134 | 3 | 24453333 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNC KALRN MYCBP2 RTTN ARHGAP17 CEP192 FAT1 PSME4 RALGPS1 EIF4G1 PYGB ZFYVE26 TOP3B TNPO3 GPAT4 | 2.49e-05 | 1105 | 134 | 15 | 35748872 |
| Pubmed | 2.50e-05 | 304 | 134 | 8 | 32235678 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 3.07e-05 | 313 | 134 | 8 | 38270169 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 3.73e-05 | 235 | 134 | 7 | 30258100 | |
| Pubmed | 3.73e-05 | 418 | 134 | 9 | 34709266 | ||
| Pubmed | 4.37e-05 | 18 | 134 | 3 | 18664271 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 22763696 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 29466725 | ||
| Pubmed | Identification of CAP as a costameric protein that interacts with filamin C. | 4.41e-05 | 3 | 134 | 2 | 17898075 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 9971820 | ||
| Pubmed | Interactions of intermediate filament protein synemin with dystrophin and utrophin. | 4.41e-05 | 3 | 134 | 2 | 16777071 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 12393796 | ||
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 4.41e-05 | 3 | 134 | 2 | 29208674 | |
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 4.41e-05 | 3 | 134 | 2 | 26507659 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 11153914 | ||
| Pubmed | Biomechanical Properties of the Sarcolemma and Costameres of Skeletal Muscle Lacking Desmin. | 4.41e-05 | 3 | 134 | 2 | 34489727 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 11252955 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 10085062 | ||
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 4.41e-05 | 3 | 134 | 2 | 24394417 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 14681216 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 10516026 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 38316082 | ||
| Pubmed | Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. | 4.41e-05 | 3 | 134 | 2 | 14661019 | |
| Pubmed | 5.09e-05 | 103 | 134 | 5 | 10819331 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 8.04e-05 | 462 | 134 | 9 | 31138677 | |
| Pubmed | 8.19e-05 | 360 | 134 | 8 | 33111431 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 8.35e-05 | 361 | 134 | 8 | 26167880 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 8.80e-05 | 4 | 134 | 2 | 22802962 | |
| Pubmed | The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. | 8.80e-05 | 4 | 134 | 2 | 25483588 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 26283199 | ||
| Pubmed | MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function. | 8.80e-05 | 4 | 134 | 2 | 29662197 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 15728831 | ||
| Pubmed | Allele-specific demethylation at an imprinted mammalian promoter. | 8.80e-05 | 4 | 134 | 2 | 17942418 | |
| Pubmed | MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. | 8.80e-05 | 4 | 134 | 2 | 11073940 | |
| Pubmed | MORC1 represses transposable elements in the mouse male germline. | 8.80e-05 | 4 | 134 | 2 | 25503965 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 31253182 | ||
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 8.80e-05 | 4 | 134 | 2 | 15953418 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 9.92e-05 | 475 | 134 | 9 | 31040226 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 1.03e-04 | 372 | 134 | 8 | 22939624 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNB FLNC UGGT1 COPB2 SPCS2 CHEK1 PTPRU SLC3A2 CSE1L PLD2 DMD ALDH3A2 TNPO3 | 1.05e-04 | 974 | 134 | 13 | 28675297 |
| Pubmed | 1.26e-04 | 66 | 134 | 4 | 19898482 | ||
| Pubmed | 1.33e-04 | 494 | 134 | 9 | 26831064 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.46e-04 | 5 | 134 | 2 | 11401426 | |
| Pubmed | 1.46e-04 | 5 | 134 | 2 | 12006559 | ||
| Pubmed | 1.46e-04 | 5 | 134 | 2 | 17360453 | ||
| Pubmed | PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERK5 pathway. | 1.46e-04 | 5 | 134 | 2 | 12912994 | |
| Pubmed | 1.46e-04 | 5 | 134 | 2 | 16787652 | ||
| Interaction | PPP1R3B interactions | 5.09e-06 | 19 | 125 | 4 | int:PPP1R3B | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 2.52e-07 | 12 | 88 | 4 | 756 | |
| GeneFamily | Fibronectin type III domain containing | 1.30e-05 | 160 | 88 | 7 | 555 | |
| GeneFamily | Glycogen phosphorylases | 7.00e-05 | 3 | 88 | 2 | 437 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.67e-04 | 26 | 88 | 3 | 253 | |
| GeneFamily | UPF1 like RNA helicases | 1.25e-03 | 11 | 88 | 2 | 1169 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B FLNB DPYD MYCBP2 KDM5A KDM4C BAZ2B POLR2B CDK19 USP24 INPP5F FAT1 CSE1L PSME4 UPF2 NMT2 VPS13A DMD PLCE1 | 2.84e-08 | 856 | 126 | 19 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | FLNB DPYD MYCBP2 KDM5A BAZ2B USP24 INPP5F FAT1 UPF2 NMT2 VPS13A | 1.62e-05 | 466 | 126 | 11 | M13522 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-08 | 184 | 126 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-08 | 184 | 126 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-08 | 184 | 126 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 7.09e-06 | 163 | 126 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 177 | 126 | 6 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 177 | 126 | 6 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 177 | 126 | 6 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-05 | 185 | 126 | 6 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-05 | 185 | 126 | 6 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.60e-05 | 188 | 126 | 6 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-05 | 200 | 126 | 6 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| Drug | AC1L2VU3 | 4.14e-07 | 12 | 125 | 4 | CID000129572 | |
| Drug | AC 110 | 6.44e-07 | 4 | 125 | 3 | CID000022860 | |
| Drug | pentasulfane | 1.50e-06 | 16 | 125 | 4 | CID000448216 | |
| Drug | AC1LCUXJ | 1.60e-06 | 5 | 125 | 3 | CID000656425 | |
| Drug | AC1O3M08 | 1.60e-06 | 5 | 125 | 3 | CID006331955 | |
| Drug | EdUMP | 3.19e-06 | 6 | 125 | 3 | CID003085112 | |
| Drug | 5'-deoxy-5'-chloroformycin | 3.19e-06 | 6 | 125 | 3 | CID000126430 | |
| Drug | 3,4-dihydroquinazoline | 3.19e-06 | 6 | 125 | 3 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 3.19e-06 | 6 | 125 | 3 | CID000133976 | |
| Drug | AC1L3372 | 5.56e-06 | 7 | 125 | 3 | CID000108025 | |
| Drug | APMPA | 5.56e-06 | 7 | 125 | 3 | CID000512300 | |
| Drug | europium | 8.52e-06 | 87 | 125 | 6 | CID000023981 | |
| Drug | Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.21e-05 | 194 | 125 | 8 | 7479_DN | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.21e-05 | 194 | 125 | 8 | 3184_DN | |
| Drug | 5'-methylthiotubercidin | 1.32e-05 | 9 | 125 | 3 | CID000188350 | |
| Drug | eniluracil | 1.38e-05 | 27 | 125 | 4 | CID000043157 | |
| Drug | 2,6-dihydroxypyridine | 1.88e-05 | 10 | 125 | 3 | CID000069371 | |
| Drug | leys | 2.58e-05 | 11 | 125 | 3 | CID000484683 | |
| Drug | gastrodin | 2.58e-05 | 11 | 125 | 3 | CID000115067 | |
| Drug | aristolactam AII | 2.99e-05 | 2 | 125 | 2 | CID000148657 | |
| Drug | alkosin | 2.99e-05 | 2 | 125 | 2 | CID005488638 | |
| Drug | norcepharadione B | 2.99e-05 | 2 | 125 | 2 | CID000189168 | |
| Drug | piperolactam A | 2.99e-05 | 2 | 125 | 2 | CID003081016 | |
| Drug | phenylurethane | 3.43e-05 | 12 | 125 | 3 | CID000007591 | |
| Drug | papaverine | 5.42e-05 | 176 | 125 | 7 | CID000004680 | |
| Drug | L-BVAU | 5.53e-05 | 38 | 125 | 4 | CID000667554 | |
| Drug | AC1Q69H9 | 5.63e-05 | 14 | 125 | 3 | CID000001814 | |
| Drug | butamben | 7.00e-05 | 15 | 125 | 3 | CID000002482 | |
| Drug | arabinosyladenine | CACNA1A CACNA1B CACNA1E POLR2B OAS3 NLRP14 NF1 UPF2 AHCY PYGB PYGM TADA2A PLD2 DDX4 | 7.77e-05 | 762 | 125 | 14 | CID000000191 |
| Drug | 5-methylthioribose-1-phosphate | 8.59e-05 | 16 | 125 | 3 | CID000000465 | |
| Drug | foscarnet | 8.78e-05 | 190 | 125 | 7 | CID000003414 | |
| Drug | 3,5-dimethylphenyl isocyanate | 8.94e-05 | 3 | 125 | 2 | CID000521488 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 8.94e-05 | 3 | 125 | 2 | CID000147839 | |
| Drug | NSC758405 | 8.94e-05 | 3 | 125 | 2 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 8.94e-05 | 3 | 125 | 2 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 8.94e-05 | 3 | 125 | 2 | CID000196007 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 8.94e-05 | 3 | 125 | 2 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 8.94e-05 | 3 | 125 | 2 | CID000191554 | |
| Drug | hydan | 8.94e-05 | 3 | 125 | 2 | CID000008360 | |
| Drug | EHMF | 8.94e-05 | 3 | 125 | 2 | CID000033931 | |
| Drug | pyridoxal 5'-methylenephosphonate | 8.94e-05 | 3 | 125 | 2 | CID003082249 | |
| Drug | Plp 5'-mpa | 8.94e-05 | 3 | 125 | 2 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 8.94e-05 | 3 | 125 | 2 | CID000191723 | |
| Drug | 3'-FFdUrd | 8.94e-05 | 3 | 125 | 2 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 8.94e-05 | 3 | 125 | 2 | CID000119518 | |
| Drug | AC1L8XK3 | 8.94e-05 | 3 | 125 | 2 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 8.94e-05 | 3 | 125 | 2 | CID000446801 | |
| Drug | riboflavin tetraacetate | 8.94e-05 | 3 | 125 | 2 | CID000094186 | |
| Drug | 2,5-dimethyl-3-furanone | 8.94e-05 | 3 | 125 | 2 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 8.94e-05 | 3 | 125 | 2 | CID000011459 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 9.07e-05 | 191 | 125 | 7 | 4168_DN | |
| Drug | homonojirimycin | 1.04e-04 | 17 | 125 | 3 | CID000159496 | |
| Drug | fagomine | 1.04e-04 | 17 | 125 | 3 | CID000072259 | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 2849_DN | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 5482_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 7206_DN | |
| Drug | meprobamate | 1.25e-04 | 88 | 125 | 5 | CID000004064 | |
| Drug | hexachlorophene | 1.39e-04 | 90 | 125 | 5 | CID000003598 | |
| Drug | pranidipine | 1.47e-04 | 19 | 125 | 3 | CID006436048 | |
| Drug | N6-Me-dAdo | 1.47e-04 | 19 | 125 | 3 | CID000168948 | |
| Drug | arabinosyluracil | 1.51e-04 | 354 | 125 | 9 | CID000001177 | |
| Drug | Dantrolene-13C3 | 1.51e-04 | 145 | 125 | 6 | CID000002951 | |
| Drug | DAPs | 1.55e-04 | 92 | 125 | 5 | CID000146339 | |
| Drug | acyclonucleoside | 1.72e-04 | 20 | 125 | 3 | CID000466144 | |
| Drug | NSC633770 | 1.77e-04 | 51 | 125 | 4 | CID000003183 | |
| Drug | trifluorothymidine | 1.77e-04 | 51 | 125 | 4 | CID000006256 | |
| Drug | galocitabine | 1.78e-04 | 4 | 125 | 2 | CID000065950 | |
| Drug | 5-deoxyribose-1-phosphate | 1.78e-04 | 4 | 125 | 2 | CID000135786 | |
| Drug | ingliforib | 1.78e-04 | 4 | 125 | 2 | CID006451325 | |
| Drug | uric acid riboside | 1.78e-04 | 4 | 125 | 2 | CID000164933 | |
| Drug | pseudo-dl-glucose | 1.78e-04 | 4 | 125 | 2 | CID000125259 | |
| Drug | pyridoxal diphosphate | 1.78e-04 | 4 | 125 | 2 | CID000125696 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 1.78e-04 | 4 | 125 | 2 | CID000189134 | |
| Drug | AC1LAMW2 | 1.78e-04 | 4 | 125 | 2 | CID000491364 | |
| Drug | FdUrd-C8 | 1.78e-04 | 4 | 125 | 2 | CID000094262 | |
| Drug | Mem-CC | 1.78e-04 | 4 | 125 | 2 | CID003081269 | |
| Drug | BCIp4A | 1.78e-04 | 4 | 125 | 2 | CID000192417 | |
| Drug | 3'-chloromethotrexate | 1.78e-04 | 4 | 125 | 2 | CID000097703 | |
| Drug | ADP beta S | 1.89e-04 | 96 | 125 | 5 | CID005310996 | |
| Drug | AC1L8YNX | 2.64e-04 | 23 | 125 | 3 | CID000410238 | |
| Drug | alpha-conotoxin SI | 2.64e-04 | 23 | 125 | 3 | CID000163979 | |
| Drug | LY320135 | 2.64e-04 | 23 | 125 | 3 | CID005311257 | |
| Drug | heptulose-2-P | 2.96e-04 | 5 | 125 | 2 | CID000124823 | |
| Drug | 6-FPLP | 2.96e-04 | 5 | 125 | 2 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 2.96e-04 | 5 | 125 | 2 | CID009576855 | |
| Drug | DHPBU | 2.96e-04 | 5 | 125 | 2 | CID000125914 | |
| Drug | almagel | 2.96e-04 | 5 | 125 | 2 | CID003080942 | |
| Drug | 5'-isobutylthioinosine | 2.96e-04 | 5 | 125 | 2 | CID003080910 | |
| Drug | S 8510 | 2.96e-04 | 5 | 125 | 2 | CID005488383 | |
| Drug | indirubin-5-sulphonate | 2.96e-04 | 5 | 125 | 2 | CID005288641 | |
| Drug | 6-amino-5-bromouracil | 2.96e-04 | 5 | 125 | 2 | CID000080578 | |
| Drug | etafenone | 2.96e-04 | 5 | 125 | 2 | CID000003275 | |
| Drug | ddEtUrd | 2.96e-04 | 5 | 125 | 2 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 2.96e-04 | 5 | 125 | 2 | CID000125618 | |
| Drug | m-anisidine | 2.96e-04 | 5 | 125 | 2 | CID000010824 | |
| Drug | 2-hydroxypropylphosphonate | 2.96e-04 | 5 | 125 | 2 | CID000441028 | |
| Drug | 6-FDPL | 2.96e-04 | 5 | 125 | 2 | CID000129578 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 2.96e-04 | 5 | 125 | 2 | CID003082179 | |
| Drug | GlcMan | 2.96e-04 | 5 | 125 | 2 | CID000152120 | |
| Drug | U66985 | 2.96e-04 | 5 | 125 | 2 | CID000127224 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 6.56e-08 | 3 | 120 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 2.62e-07 | 4 | 120 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 2.27e-06 | 7 | 120 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 4.91e-05 | 3 | 120 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 4.91e-05 | 3 | 120 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | stomach carcinoma (is_marker_for) | 1.25e-04 | 24 | 120 | 3 | DOID:5517 (is_marker_for) | |
| Disease | Colorectal Carcinoma | FLNC DPYD KALRN PTPRU ITPRID1 FAT1 CSE1L NF1 EIF4G1 VPS13A DMD | 1.42e-04 | 702 | 120 | 11 | C0009402 |
| Disease | HOMA-IR | 3.27e-04 | 33 | 120 | 3 | EFO_0004501 | |
| Disease | Developmental regression | 3.40e-04 | 7 | 120 | 2 | C1836830 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 4.52e-04 | 8 | 120 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 4.66e-04 | 157 | 120 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 4.99e-04 | 38 | 120 | 3 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | Intellectual Disability | 4.99e-04 | 447 | 120 | 8 | C3714756 | |
| Disease | cognitive function measurement, self reported educational attainment | 6.40e-04 | 355 | 120 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | autistic disorder (is_implicated_in) | 6.71e-04 | 42 | 120 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | response to carboplatin, response to antineoplastic agent | 7.23e-04 | 10 | 120 | 2 | GO_0097327, GO_0097328 | |
| Disease | alopecia areata (is_marker_for) | 7.23e-04 | 10 | 120 | 2 | DOID:986 (is_marker_for) | |
| Disease | biliary liver cirrhosis | 7.69e-04 | 44 | 120 | 3 | EFO_0004267 | |
| Disease | sleep disorder (implicated_via_orthology) | 8.81e-04 | 11 | 120 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 1.24e-03 | 13 | 120 | 2 | C1846647 | |
| Disease | optic cup area measurement | 1.55e-03 | 56 | 120 | 3 | EFO_0006940 | |
| Disease | systemic lupus erythematosus, COVID-19 | 1.72e-03 | 58 | 120 | 3 | MONDO_0007915, MONDO_0100096 | |
| Disease | macrophage inflammatory protein 1b measurement | 2.35e-03 | 136 | 120 | 4 | EFO_0008219 | |
| Disease | phosphatidylcholine 36:4 measurement | 2.40e-03 | 18 | 120 | 2 | EFO_0010382 | |
| Disease | Autosomal Recessive Primary Microcephaly | 3.59e-03 | 22 | 120 | 2 | C3711387 | |
| Disease | glaucoma | 3.67e-03 | 154 | 120 | 4 | MONDO_0005041 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EWPPFEYMILATIIA | 96 | O00555 | |
| DWEDIRKMPEYPTLQ | 266 | Q9BWU1 | |
| WEAEINPHMSSYVPI | 6 | Q9NQI0 | |
| IDWPPFEYMILATII | 86 | Q15878 | |
| MAVPFVEDWDLVQTL | 1 | O14757 | |
| ESENPLEMFETVPVW | 171 | Q9UJW3 | |
| PEGFPEDELMTWQFV | 241 | Q9H5V8 | |
| VDLHPTEPWMLASLY | 21 | P35606 | |
| METHEDAWPFLLPVN | 2076 | Q9UIF8 | |
| PVDAIVLEAPFTNMW | 236 | Q7Z5M8 | |
| PFDEKMDPWLSELVE | 2671 | Q8TCU4 | |
| MDPWLSELVEPAFVP | 2676 | Q8TCU4 | |
| GEIDFMLENLPEWVT | 66 | P51648 | |
| LPEVDPETMQTSEAW | 461 | Q12882 | |
| VVNLDVPLDWETYMH | 381 | Q9UHI6 | |
| METPVTLINFWPVDS | 3406 | P11532 | |
| SVLVDWMIPDIPTDI | 921 | Q9NQ90 | |
| LTLVWEPEDMEQEPA | 816 | Q8IYB7 | |
| ITEWPPFEYMILATI | 91 | Q00975 | |
| VTEALVSMIFPFHWP | 431 | Q7Z401 | |
| LWVPDEEVSPETMVK | 811 | Q9NTI5 | |
| WMVQLPDDPEHPDIF | 496 | Q5JS13 | |
| DPITARESIWLPFME | 46 | O75884 | |
| SDWMPSVPLPDIQEF | 4386 | Q14517 | |
| LSEIDWMNPIFVPEE | 1191 | Q5KSL6 | |
| PAVVWIDSTLHQPMF | 51 | Q6IF63 | |
| EEWVVPYIEMDSPIL | 101 | O95751 | |
| PVMDEEEVAHWFLPR | 366 | O60551 | |
| MIEWFPDVDSEPTTL | 356 | Q8NI17 | |
| WQLLPMPHAEYEVTR | 541 | Q6ZRS4 | |
| MYIIPPQDWLDRGDE | 301 | Q9HCQ5 | |
| TPEEEPTGMLDVWYM | 316 | Q99665 | |
| PWVTEEAYVPVSDMN | 1726 | O75369 | |
| KEFFDVWPVLMGEVP | 286 | P16499 | |
| YWEELMDTTRPDIEV | 146 | Q9H4M3 | |
| WATEEPVVPVEPMES | 1766 | Q14315 | |
| TYLWEMTSGVEEIPP | 1306 | O60229 | |
| VVEMLTEKPPWAEFE | 551 | Q9Y2U5 | |
| VLMEPDDWPYVVNIT | 846 | Q9H3R0 | |
| SPFWMENPYVKVDTI | 146 | P54753 | |
| LLLPWSMLPDVVDDF | 386 | A6NFX1 | |
| PVHMVPTELVEKEFW | 381 | P29375 | |
| FTPLEDMIFLKWEEP | 496 | Q92729 | |
| AFLLPWSMLPDVIDD | 411 | Q8NA29 | |
| HTAVPEVMLPVWFTA | 111 | Q9NZ94 | |
| DTEAWQFPVTLEPMP | 276 | P87889 | |
| DTEAWQFPVTLEPMP | 276 | Q9YNA8 | |
| DTEAWQFPVTLEPMP | 276 | P63145 | |
| DTEAWQFPVTLEPMP | 276 | Q7LDI9 | |
| DTEAWQFPVTLEPMP | 276 | P63130 | |
| DTEAWQFPVTLEPMP | 276 | P62685 | |
| DTEAWQFPVTLEPMP | 276 | P63126 | |
| DTEAWQFPVTLELMP | 276 | P62684 | |
| SVILQWVVTMDPEPV | 66 | A1L1A6 | |
| PDRWTEYSIQTMEPD | 211 | Q9NPB8 | |
| YEPETNQWTLIAPMH | 406 | Q6JEL2 | |
| DVTHSTMNVFWEPVP | 1576 | Q99715 | |
| WYLPPMTREADEDAV | 386 | Q86UL3 | |
| MPDIIWVFPPQAEAE | 1 | Q9UK97 | |
| FETLGTPTEEQWPDM | 226 | P50613 | |
| PPEWEEDEERMSFLF | 21 | Q8WUX9 | |
| PLVLLMEWPEATNFA | 466 | Q5JV73 | |
| YPVLPHVQKSEEMWI | 266 | Q3MJ40 | |
| APVMLWDESSFPDIP | 486 | P08195 | |
| FDMPHSWVEQIEISP | 411 | Q8IY82 | |
| AEDMEIDIPHVWLYL | 1326 | Q04637 | |
| MYVPDEWEVPREQIS | 966 | P14616 | |
| QDPEFLMIWVLFHSP | 1586 | Q8TEP8 | |
| MAWPEDHVFISTPSF | 281 | P04180 | |
| RYIEEPLEEAMPCWL | 166 | Q17R55 | |
| PWSKLVPQFEFDPEM | 2431 | Q9NYC9 | |
| YPVLPHVQKSEEMWI | 266 | A2RUR9 | |
| VKPMDIEESIWSPRF | 256 | P51530 | |
| PSDPVEWTVMDVVEY | 456 | Q6SPF0 | |
| VMAQIELWTHPDKYP | 366 | P23526 | |
| MDIDHILDWQPPEVI | 66 | Q9UDX4 | |
| EIGTPDVDFWIIPMI | 221 | Q9Y2H2 | |
| WPHTIPYVLEDSLEM | 71 | Q16820 | |
| TVVEMLTEKPPWAEY | 556 | Q99759 | |
| VVLVIEDSWLHNPMY | 76 | Q8NGG3 | |
| VFSDQPWLEIPPFVM | 16 | Q9GZK3 | |
| VWTKDHPFPIDIDYM | 961 | Q9HAU5 | |
| VDLEDWMDVSLVPAF | 136 | Q9Y6K5 | |
| LQEPEAPEVMFELLW | 41 | Q6P0A1 | |
| NMFEYLPTWVEPDPE | 406 | A6ND36 | |
| DPVWHEQVIFKEMFP | 301 | Q2WGJ9 | |
| EPQHTIPDVFIWMLS | 711 | Q2WGJ9 | |
| EWFNFPSVPMKEEVL | 51 | Q86VV8 | |
| EWVYVNEPVPEEMPL | 1011 | Q9C093 | |
| EEMPLFLVPYWELIE | 1021 | Q9C093 | |
| YDVLNAPLEMTVWVP | 521 | Q6IEE7 | |
| PEIVIWAEHVENMPS | 321 | O15061 | |
| YEIMTSDFPVLDPSW | 61 | O75478 | |
| LPEMVRFEPTWEELE | 346 | Q9Y2G5 | |
| RHYDLESVPMTWDPV | 356 | Q9HCE1 | |
| PEEEIMQILSSWFPE | 2086 | Q9P212 | |
| LPEPLMTFNLYEEWT | 331 | Q68EM7 | |
| TVTMEDLIRPWFPEF | 376 | Q9Y289 | |
| FPATFVTAEMVPWEP | 326 | Q9BQS7 | |
| SQPSPILEFLEEWSM | 536 | P30876 | |
| FPECVRWMTIEFDPQ | 2041 | O75592 | |
| VTLVPEEPEDMWHTY | 16 | Q9BRX2 | |
| LAPEPEETWVVEMLC | 86 | A6NHP3 | |
| EEEAPSWDELAVMIP | 161 | Q9H2D6 | |
| LEITWYPFDVEDMTA | 311 | Q9Y4F9 | |
| DTEAWQFPVTLEPMP | 276 | P63128 | |
| EPFSLWVFPQEMVLE | 61 | Q96NS8 | |
| GFTEVMPWQSVPLEE | 451 | O95985 | |
| EDFPQKWPDLLTEMV | 121 | P55060 | |
| NEMFGVWEPLLEPLE | 1776 | Q96RL7 | |
| LEYWPRTHVNPMDEE | 471 | Q8TAF3 | |
| WVDTQVVLAMPYDTP | 216 | P11217 | |
| EVEELDNWQPAVPLM | 271 | Q496A3 | |
| LPSFAVEIMPEWVFV | 176 | Q71H61 | |
| IVALIWDYMHPFPES | 96 | Q15005 | |
| LAPEPEETWVVEMLC | 46 | A6NNV3 | |
| LAPEPEETWVVEMLC | 86 | P0DV79 | |
| LAPEPEETWVVEMLC | 86 | Q495Y8 | |
| LAPEPEETWVVEMLC | 86 | A6NIY4 | |
| LAPEPEETWVVEMLC | 86 | P0CI01 | |
| WLDTQVVLAMPYDTP | 216 | P11216 | |
| QGVPWEYIPFEALIM | 316 | Q9HBJ7 | |
| PEEVFMAIRNPLEWH | 2356 | P21359 | |
| PLDRAVFWIEFVMPH | 456 | O75310 | |
| ADLELPWRPLYDMVE | 136 | Q14997 | |
| NPPWEVTEAVLFIMA | 431 | Q9Y5L0 | |
| EEPFMPAWEVVTSAI | 71 | Q6PK81 | |
| TMLEDEITWLDNFEP | 1536 | Q9UPU5 | |
| LAPEPEETWVVEMLC | 46 | A6NJR5 | |
| VPQAMEWLIEHAEDP | 221 | Q9BSL1 | |
| VEPLDLAVFWVEFVM | 451 | P19224 | |
| RELWETYHMPDVELL | 231 | A6NLI5 | |
| RMDEQELTEPVWCPY | 831 | Q9BZH6 | |
| FEDFIDRETTPRMPW | 526 | O14939 | |
| SGDPIPMLQEDFWIS | 936 | Q68DK2 | |
| QLDWPDPEEAFMITV | 646 | Q70J99 | |
| TPESWMVESVRTPYD | 1076 | Q9NYU2 | |
| IYLMVIWELPDVVPF | 586 | B1ANS9 | |
| PVDILIMDDDDVPSW | 26 | Q6DD87 | |
| ERYDPKTDTWTMVAP | 671 | Q9NR64 | |
| DWPSTEGPIEEIMYQ | 236 | Q86W24 |